Gilbert S Omenn - Net Worth and Insider Trading

Gilbert S Omenn Net Worth

The estimated net worth of Gilbert S Omenn is at least $53 Million dollars as of 2024-11-13. Gilbert S Omenn is the Director of Amgen Inc and owns about 176,783 shares of Amgen Inc (AMGN) stock worth over $53 Million. Gilbert S Omenn is the Director of Galectin Therapeutics Inc and owns about 66,769 shares of Galectin Therapeutics Inc (GALT) stock worth over $196,969. Gilbert S Omenn is also the Director of Esperion Therapeutics Inc and owns about 11,000 shares of Esperion Therapeutics Inc (ESPR) stock worth over $26,785. Besides these, Gilbert S Omenn also holds Amesite Inc (AMST) . Details can be seen in Gilbert S Omenn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gilbert S Omenn has not made any transactions after 2021-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gilbert S Omenn

To

Gilbert S Omenn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gilbert S Omenn owns 7 companies in total, including Amesite Inc (AMST) , Galectin Therapeutics Inc (GALT) , and Esperion Therapeutics Inc (ESPR) among others .

Click here to see the complete history of Gilbert S Omenn’s form 4 insider trades.

Insider Ownership Summary of Gilbert S Omenn

Ticker Comapny Transaction Date Type of Owner
AMST Amesite Inc 2023-09-29 director
GALT Galectin Therapeutics Inc 2020-01-09 director
ESPR Esperion Therapeutics Inc 2017-03-21 director
LIMIT LIMIT 2012-11-26 director
LIMIT LIMIT 2007-07-03 director
LIMIT LIMIT 2021-02-04 director
LIMIT LIMIT 2021-02-04 director

Gilbert S Omenn Latest Holdings Summary

Gilbert S Omenn currently owns a total of 4 stocks. Among these stocks, Gilbert S Omenn owns 176,783 shares of Amgen Inc (AMGN) as of November 26, 2012, with a value of $53 Million and a weighting of 99.55%. Gilbert S Omenn owns 66,769 shares of Galectin Therapeutics Inc (GALT) as of May 31, 2019, with a value of $196,969 and a weighting of 0.37%. Gilbert S Omenn also owns 11,000 shares of Esperion Therapeutics Inc (ESPR) as of March 21, 2017, with a value of $26,785 and a weighting of 0.05%. The other 1 stocks Amesite Inc (AMST) have a combined weighting of 0.03% among all his current holdings.

Latest Holdings of Gilbert S Omenn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2012-11-26 176,783 298.84 52,829,832
GALT Galectin Therapeutics Inc 2019-05-31 66,769 2.95 196,969
ESPR Esperion Therapeutics Inc 2017-03-21 11,000 2.44 26,785
AMST Amesite Inc 2021-12-14 6,472 2.64 17,054

Holding Weightings of Gilbert S Omenn


Gilbert S Omenn Form 4 Trading Tracker

According to the SEC Form 4 filings, Gilbert S Omenn has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 26,000 shares on November 26, 2012, which brought Gilbert S Omenn around $2 Million.

According to the SEC Form 4 filings, Gilbert S Omenn has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 18,578 shares on May 31, 2019, which cost Gilbert S Omenn around $79,514.

According to the SEC Form 4 filings, Gilbert S Omenn has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 1,000 shares on March 21, 2017, which cost Gilbert S Omenn around $42,260.

More details on Gilbert S Omenn's insider transactions can be found in the Insider Trading History of Gilbert S Omenn table.

Insider Trading History of Gilbert S Omenn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gilbert S Omenn Trading Performance

GuruFocus tracks the stock performance after each of Gilbert S Omenn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gilbert S Omenn is -11.99%. GuruFocus also compares Gilbert S Omenn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gilbert S Omenn within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gilbert S Omenn's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gilbert S Omenn

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.46 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.97 LIMIT LIMIT LIMIT LIMIT LIMIT

Gilbert S Omenn Ownership Network

Ownership Network List of Gilbert S Omenn

No Data

Ownership Network Relation of Gilbert S Omenn

Insider Network Chart

Gilbert S Omenn Owned Company Details

What does Amesite Inc do?

Who are the key executives at Amesite Inc?

Gilbert S Omenn is the director of Amesite Inc. Other key executives at Amesite Inc include director & Chief Executive Officer Ann Marie Sastry , Chief Financial Officer Sherrie Farrell , and Chief Financial Officer Mark Corrao .

Amesite Inc (AMST) Insider Trades Summary

Over the past 18 months, Gilbert S Omenn made no insider transaction in Amesite Inc (AMST). Other recent insider transactions involving Amesite Inc (AMST) include a net purchase of 10,000 shares made by Ann Marie Sastry ,

In summary, during the past 3 months, insiders sold 0 shares of Amesite Inc (AMST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Amesite Inc (AMST) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.

Amesite Inc (AMST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amesite Inc Insider Transactions

No Available Data

Gilbert S Omenn Mailing Address

Above is the net worth, insider trading, and ownership report for Gilbert S Omenn. You might contact Gilbert S Omenn via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.